Parnassus Investments
Parnassus Endeavor Fund
Parnassus Endeavor Fund 13F holdings
Parnassus Endeavor Fund's Portfolio
- Portfolio value:
- $5.39B~
- # of securities:
- 52 (+2)
- Reported for:
- 31 Mar 2022 (Q1)
- Latest filing date:
- 24 May 2022
What stocks did Parnassus Endeavor Fund own in 2022 Q1?
What was Parnassus Endeavor Fund's 2022 Q1 portfolio?
Parnassus Endeavor Fund has disclosed a total of 52 security holdings in their (2022 Q1) SEC filing(s) with portfolio value of $5,389,344,097.
Parnassus Endeavor Fund's portfolio holdings are tracked quarterly based on SEC filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Parnassus Endeavor Fund's original SEC reports (2022 Q1) are the official SEC institutional disclosure documents covering all reported equity positions.
52 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Charles Schwab Corp
|
3.69%
|
2,360,908
|
$84.31
|
+28.09%($107.99)
|
$199,048,153
|
2021 Q4
|
~0.50 years
|
|
|
|
|
|
Merck & Company Inc
|
3.51%
|
2,306,548
|
$82.05
|
+84.09%($151.04)
|
$189,252,263
|
2021 Q4
|
~0.50 years
|
|
|
|
|
|
Verizon Communications Inc
|
3.33%
|
3,521,415
|
$50.94
|
-2.43%($49.70)
|
$179,380,880
|
2021 Q4
|
~0.50 years
|
|
|
|
|
|
Cisco Systems Inc
|
3.10%
|
3,000,000
|
$55.76
|
+100.22%($111.64)
|
$167,280,000
|
2021 Q4
|
~0.50 years
|
|
|
|
|
|
Intel Corp
|
3.03%
|
3,297,764
|
$49.56
|
+83.13%($90.76)
|
$163,437,184
|
2021 Q4
|
~0.50 years
|
|
|
|
|
|
Sysco Corp
|
2.99%
|
1,975,976
|
$81.65
|
+1.20%($82.63)
|
$161,338,440
|
2021 Q4
|
~0.50 years
|
+6.58% (+121.91K)
|
+0.18%
|
|
|
|
Global Payments Inc
|
2.87%
|
1,128,745
|
$136.84
|
-32.69%($92.11)
|
$154,457,466
|
2021 Q4
|
~0.50 years
|
+6.48% (+68.68K)
|
+0.17%
|
|
|
|
PepsiCo Inc
|
2.84%
|
915,459
|
$167.38
|
-16.10%($140.42)
|
$153,229,527
|
2021 Q4
|
~0.50 years
|
|
|
|
|
|
Vertex Pharmaceuticals Inc
|
2.77%
|
571,485
|
$260.97
|
+110.16%($548.46)
|
$149,140,440
|
2021 Q4
|
~0.50 years
|
-7.74% (-47.95K)
|
-0.23%
|
|
|
|
S&P Global Inc
|
2.52%
|
331,514
|
$410.18
|
+6.90%($438.49)
|
$135,980,413
|
2021 Q4
|
~0.50 years
|
+17.77% (+50.01K)
|
+0.38%
|
|
Completely sold out
7 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Intuit Inc
|
-110,012
|
-1.31%
|
2021 Q4
|
~0.25 years
|
|
|
|
Illumina Inc
|
-159,393
|
-1.12%
|
2021 Q4
|
~0.25 years
|
|
|
|
CDARS MATU 031622
|
-501,128.78
|
-0.01%
|
2021 Q4
|
~0.25 years
|
|
|
|
SELFHELP FEDERAL CREDIT UNION
|
-250,000
|
-0%
|
2021 Q4
|
~0.25 years
|
|
|
|
COMMUNITY VISION CAPITAL CONSULTING
|
-250,000
|
-0%
|
2021 Q4
|
~0.25 years
|
|
|
|
ROOT CPTL LOAN PEF
|
-100,000
|
-0%
|
2021 Q4
|
~0.25 years
|
|
|
|
WASHINGTON AREA COMMUNITY INVESTMENT FUND
|
-100,000
|
-0%
|
2021 Q4
|
~0.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".
* % of portfolio: the total can exceed 100%, e.g. when there are also options positions, which can be short.